BRPI0509323A - processo para a preparação de um composto - Google Patents
processo para a preparação de um compostoInfo
- Publication number
- BRPI0509323A BRPI0509323A BRPI0509323-6A BRPI0509323A BRPI0509323A BR PI0509323 A BRPI0509323 A BR PI0509323A BR PI0509323 A BRPI0509323 A BR PI0509323A BR PI0509323 A BRPI0509323 A BR PI0509323A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- formula
- alkyl
- solvent
- preparation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 239000003054 catalyst Substances 0.000 abstract 2
- 239000002904 solvent Substances 0.000 abstract 2
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 abstract 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 abstract 1
- 239000004215 Carbon black (E152) Substances 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229930195733 hydrocarbon Natural products 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 238000005984 hydrogenation reaction Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 229910052723 transition metal Inorganic materials 0.000 abstract 1
- 150000003624 transition metals Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
"PROCESSO PARA A PREPARAçãO DE UM COMPOSTO" A presente invenção fornece um processo para a reparação de um composto de formula (I): em que X é halogênio; Y é ZR; Z é oxigênio ou enxofre e R¹ é C1-6 alquila,C1-6 haloalquila ou C3-7 cicloalquila; o processo compreendendo: a hidrogenação de um composto de fórmula (II) com um catalisador de metal de transição adequado em um álcool alifático C1-6, um éter, um hidrocarboneto como o solvente; ou b) a condução de uma hidrogenação em um único reator de um composto de fórmula (III): em que R² é fenila opcionalmente substituído por cloro, C1-6 alquila, C1-6 alcóxi ou (C1-6 alquila)2N; primeiro em torno de 20 C para formar um composto de fórmula (IV): e então em torno de 40 C; ambas as etapas (i) e (ii) sendo realizadas na presença de um catalisador adequado e na presença de um solvente adequado.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401001A SE0401001D0 (sv) | 2004-03-31 | 2004-03-31 | Chemical process |
| PCT/GB2005/001188 WO2005095358A2 (en) | 2004-03-31 | 2005-03-29 | Process for the preparation of aminopyrimidines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0509323A true BRPI0509323A (pt) | 2007-09-04 |
Family
ID=32294337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0509323-6A BRPI0509323A (pt) | 2004-03-31 | 2005-03-29 | processo para a preparação de um composto |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7799914B2 (pt) |
| EP (2) | EP1751117B1 (pt) |
| JP (1) | JP5059599B2 (pt) |
| KR (1) | KR101164265B1 (pt) |
| CN (2) | CN1938284B (pt) |
| AT (1) | ATE517096T1 (pt) |
| AU (1) | AU2005227727B2 (pt) |
| BR (1) | BRPI0509323A (pt) |
| CA (1) | CA2560094C (pt) |
| CY (1) | CY1111847T1 (pt) |
| DK (1) | DK1751117T3 (pt) |
| ES (1) | ES2368069T3 (pt) |
| HR (1) | HRP20110658T1 (pt) |
| IL (1) | IL177998A (pt) |
| NO (1) | NO20064117L (pt) |
| NZ (2) | NZ587999A (pt) |
| PL (1) | PL1751117T3 (pt) |
| PT (1) | PT1751117E (pt) |
| SE (1) | SE0401001D0 (pt) |
| SG (1) | SG151311A1 (pt) |
| SI (1) | SI1751117T1 (pt) |
| WO (1) | WO2005095358A2 (pt) |
| ZA (1) | ZA200607708B (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401001D0 (sv) * | 2004-03-31 | 2004-03-31 | Astrazeneca Ab | Chemical process |
| US8114996B2 (en) * | 2006-02-13 | 2012-02-14 | Lonza Ag | Reduction of 5-(aryl-diazenyl)-4,6-dihalo-pyrimidine |
| RU2509082C2 (ru) | 2008-09-09 | 2014-03-10 | Астразенека Аб | СПОСОБ ПОЛУЧЕНИЯ [1S-[1α,2α,3β(1S*,2R*),5β]]-3-[7-[2-(3,4-ДИФТОРФЕНИЛ)-ЦИКЛОПРОПИЛАМИНО]-5-(ПРОПИЛТИО)-3H-1,2,3-ТРИАЗОЛО[4,5-d]ПИРИМИДИН-3-ИЛ]-5-(2-ГИДРОКСИЭТОКСИ)-ЦИКЛОПЕНТАН-1,2-ДИОЛА И ЕГО ПРОМЕЖУТОЧНЫХ СОЕДИНЕНИЙ |
| EP2305376A1 (en) * | 2009-09-23 | 2011-04-06 | Lonza Ltd. | Process and catalyst for the catalytic hydrogenation of aromatic and heteroaromatic nitro compounds |
| US9233966B2 (en) | 2012-04-05 | 2016-01-12 | Dr. Reddy's Laboratories Limited | Preparation of ticagrelor |
| CN103130726A (zh) * | 2013-02-07 | 2013-06-05 | 许学农 | 替卡格雷中间体4,6-二氯-2-(丙巯基)-5-氨基嘧啶的制备方法 |
| WO2014206187A1 (zh) | 2013-06-24 | 2014-12-31 | 苏州明锐医药科技有限公司 | 替卡格雷及其中间体的制备方法 |
| KR102325163B1 (ko) | 2013-08-22 | 2021-11-11 | 제넨테크, 인크. | 화합물의 제조 방법 |
| CN103588712B (zh) * | 2013-11-08 | 2016-06-08 | 南京欧信医药技术有限公司 | 一种嘧啶类化合物及其制备方法、和应用 |
| CN103923020A (zh) * | 2014-04-02 | 2014-07-16 | 黄河三角洲京博化工研究院有限公司 | 一种2-丙硫基-4,6-二氯-5-氨基嘧啶的制备方法 |
| CN105020602B (zh) * | 2014-04-30 | 2017-12-08 | 欧普照明股份有限公司 | 一种led灯 |
| CN103992277A (zh) * | 2014-05-16 | 2014-08-20 | 苏州天马精细化学品股份有限公司 | 一种替卡格雷中间体4,6-二氯-5-氨基-2-丙硫基嘧啶的制备方法 |
| CN105294573B (zh) * | 2015-06-16 | 2018-07-10 | 厦门医学院 | 一种合成4,6-二氯-2-(丙硫基)-5-氨基嘧啶的方法 |
| CN116283796A (zh) * | 2023-02-14 | 2023-06-23 | 上海汇伦医药股份有限公司 | 一种循环催化氢化硝基化合物的方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0508687B1 (en) | 1991-04-06 | 1995-09-13 | Astra Pharmaceuticals Limited | ATP analogues |
| ES2154825T3 (es) | 1995-05-19 | 2001-04-16 | Novartis Ag | Procedimiento para la hidrogenacion catalitica de nitro compuestos aromaticos. |
| AR017014A1 (es) | 1997-07-22 | 2001-08-22 | Astrazeneca Ab | Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos |
| TWI229674B (en) | 1998-12-04 | 2005-03-21 | Astra Pharma Prod | Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses |
| GB0013488D0 (en) * | 2000-06-02 | 2000-07-26 | Astrazeneca Ab | Chemical compound |
| US6818720B2 (en) * | 2001-11-08 | 2004-11-16 | Degussa Ag | Supported hydrogenating catalyst in powder form |
| SE0401001D0 (sv) * | 2004-03-31 | 2004-03-31 | Astrazeneca Ab | Chemical process |
-
2004
- 2004-03-31 SE SE0401001A patent/SE0401001D0/xx unknown
-
2005
- 2005-03-29 AU AU2005227727A patent/AU2005227727B2/en not_active Ceased
- 2005-03-29 NZ NZ587999A patent/NZ587999A/en not_active IP Right Cessation
- 2005-03-29 DK DK05729737.6T patent/DK1751117T3/da active
- 2005-03-29 CA CA2560094A patent/CA2560094C/en not_active Expired - Fee Related
- 2005-03-29 CN CN2005800102841A patent/CN1938284B/zh not_active Expired - Lifetime
- 2005-03-29 PL PL05729737T patent/PL1751117T3/pl unknown
- 2005-03-29 PT PT05729737T patent/PT1751117E/pt unknown
- 2005-03-29 CN CN201010206146A patent/CN101851212A/zh active Pending
- 2005-03-29 SI SI200531366T patent/SI1751117T1/sl unknown
- 2005-03-29 JP JP2007505626A patent/JP5059599B2/ja not_active Expired - Fee Related
- 2005-03-29 NZ NZ550128A patent/NZ550128A/en not_active IP Right Cessation
- 2005-03-29 EP EP05729737A patent/EP1751117B1/en not_active Expired - Lifetime
- 2005-03-29 WO PCT/GB2005/001188 patent/WO2005095358A2/en not_active Ceased
- 2005-03-29 HR HR20110658T patent/HRP20110658T1/hr unknown
- 2005-03-29 KR KR1020067021443A patent/KR101164265B1/ko not_active Expired - Fee Related
- 2005-03-29 BR BRPI0509323-6A patent/BRPI0509323A/pt not_active Application Discontinuation
- 2005-03-29 AT AT05729737T patent/ATE517096T1/de active
- 2005-03-29 US US10/599,377 patent/US7799914B2/en not_active Expired - Fee Related
- 2005-03-29 EP EP10179703A patent/EP2308853A1/en not_active Withdrawn
- 2005-03-29 SG SG200902108-0A patent/SG151311A1/en unknown
- 2005-03-29 ES ES05729737T patent/ES2368069T3/es not_active Expired - Lifetime
-
2006
- 2006-09-11 IL IL177998A patent/IL177998A/en not_active IP Right Cessation
- 2006-09-13 NO NO20064117A patent/NO20064117L/no not_active Application Discontinuation
- 2006-09-14 ZA ZA200607708A patent/ZA200607708B/en unknown
-
2010
- 2010-08-31 US US12/871,993 patent/US20100324289A1/en not_active Abandoned
-
2011
- 2011-09-15 CY CY20111100890T patent/CY1111847T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0509323A (pt) | processo para a preparação de um composto | |
| BR112013001335A2 (pt) | processo de preparo de derivados de amino-benzoil-benzofurano | |
| AR079491A1 (es) | Metodos de sintesis de inhibidores del factor xa tal como el betrixaban y composiciones farmaceuticas que contienen la base libre de betrixaban o su sal sustancialmente pura. | |
| BRPI1013482B8 (pt) | método para produzir um composto | |
| BR112012033465A2 (pt) | método para preparar um composto | |
| BR112012020058A2 (pt) | preparação de benzofuranos e uso dos mesmos como intermediários sintéticos. | |
| PE20150877A1 (es) | Composicion herbicida que tiene actividad herbicida mejorada | |
| BR112015015429A2 (pt) | preparação de um catalisador de conversão de hidrocarboneto | |
| BR112012028846A2 (pt) | processo para produção de olefinas leves a partir de gás de síntase | |
| BR112013001365A2 (pt) | processo de preparo de derivados de benzofurano substituídos na posição 5 | |
| PE20061450A1 (es) | Proceso para la preparacion de derivados de sulfamida | |
| BR112013000593A2 (pt) | conversão de álcoois | |
| UY30682A1 (es) | Nueva difenilazetidinona sustituida con acido piperazina-1-sulfonico con propiedades farmacologicas mejoradas | |
| BR112012026456A2 (pt) | processo para preparação de amidas do ácido pirazol carboxílico | |
| BR112014014604A2 (pt) | processo para a preparação de um composto, e, composto isolado e purificado | |
| PE20120809A1 (es) | Antagonistas ccr3 arilsulfonamida 2,5-disustituidos | |
| AR073773A1 (es) | Metodo para producir decitabina protegida beta-enriquecida. | |
| BR112014015430A8 (pt) | formulação oftálmica | |
| AR074630A1 (es) | Proceso para preparar acidos 1-hidroxialquiliden-1,1-bifosfonicos | |
| ATE554074T1 (de) | Verfahren zur herstellung von 4'-ää4-methyl-6-(1- methyl-1h-benzimidazol-2-yl)-2-propyl-1h- | |
| BR112015007821A2 (pt) | processo para a preparação de voriconazol e análogos do mesmo | |
| BR112012026720A2 (pt) | processo para a preparação de amidas do ácido pirazol carboxílico | |
| BR112014009142A8 (pt) | processo de produção para ácido orgânico usando coa-transferase | |
| RU2010115567A (ru) | Способ получения замещенных 1,4-хинонметидов и способ получения 3,5-дизамещенных 4-гидроксибензальдегидов (варианты) | |
| BR112014014477A2 (pt) | método para preparar um inibidor de amina impedida e composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 13, 22 E 25 DA LPI. |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |